Jul 2 |
Heron Therapeutics announces acceptance of PAS application for dual-acting anesthetic
|
Jul 2 |
Merck (MRK) Gets Exclusive Rights to Opevesostat From Partner
|
Jul 2 |
Heron Therapeutics Announces Acceptance of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN")
|
Jun 30 |
With 55% ownership of the shares, Heron Therapeutics, Inc. (NASDAQ:HRTX) is heavily dominated by institutional owners
|
Jun 27 |
Heron Therapeutics: Opioid-Free Surgical Pain Relief Maven With Low Cash Reserves
|
Jun 25 |
Ionis Pharmaceuticals (IONS) Soars 6.8%: Is Further Upside Left in the Stock?
|
Jun 13 |
Avidity (RNA) Up 33% on Rare Muscle Disease Study Results
|
Jun 13 |
FDA Expands AstraZeneca's (AZN) Farxiga Label in Pediatric T2D
|
Jun 12 |
Viridian (VRDN) Up 10% on Clinical Updates for Eye Disease Drug
|
Jun 6 |
Amgen's (AMGN) Uplizna Meets Study Goal for Rare Disease
|